PubMed HealthSearch

Biomedical subjects

N Weiler

Publications and source records attributed to N Weiler.

10 recordsLinked to original sources

[An innovative procedure of oxygen detection in medicine, biology, environmental research and biotechnology based on luminescence quenching].

For most (aerobic) animal organisms, oxygen is a mandatory and global substrate. The accurate measurement of oxygen is therefore of importance in the fields of medicine, biology, environmental research and biotechnology. The fact that oxygen is not readily soluble in aqueous media makes its detection more difficult. In contrast to the technique of polarography, the use of luminescence quenching by paramagnetic oxygen, does not consume the oxygen. Another problem of oxygen detection in connection with respiration is the need for very short response times. A third problem, which is associated with luminescence itself, is the fading of the dyes, which results in long-term signal instability. The last two problems can be optimally resolved by adsorbing the luminescence dye onto chromatographic materials--in particular hydrophobic material--having a very large internal surface area, and using the decay time in accordance with the Stern-Volmer equation as oxygen signal. For this, continuous evaluation of the signal is necessary. The carrier material doped with dye is incorporated in a single-grain layer. For measurements in liquids, the detector layer is protected by a black silicone membrane. Two designs are possible for the oxygen detector: (I) a special form using glass fibres, and (II) a miniature detector utilizing optoelectronic solid state technology. Both fluorescence and phosphorescence can be employed, the dye used being excited by light, obviating the need for quartz. The detector layers may be either of high sensitivity for small oxygen concentrations, or have equal sensitivity over the entire oxygen concentration range. There is an optimal figure for the specific amount of adsorbed dye. Application examples are given for respiration and for the determination of oxygen uptake by suspended cells.

Animals

[Experiments aimed at developing an implantable and continuously functioning glucose sensors based on polarimetry].

In vitro and in vivo experiments devised with the aim of developing a permanently implantable glucose sensor based on polarimetry are described. It was found that in ultrafiltrated human blood plasma the overall optical rotation was 94% specific for glucose, and that polarisation photometry yielded a sufficiently sensitive signal for in vivo glucose detection. The three types of capillary membrane intended for implantation that we tested, revealed an in vitro response time to glucose concentration of 10 minutes; when implanted, they maintain this over a period of weeks, during which time the same glucose concentrations can be measured daily in ultrafiltrated capillary fluid as in the blood of the animals (guinea pigs). The drop in glucose concentration induced 20 minutes after a single administration of insulin can also be detected in both fluids. The experiments described indicate that the development of an implantable polarimetric glucose sensor is possible.

Animals

The AVL-mode: a safe closed loop algorithm for ventilation during total intravenous anesthesia.

The Adaptive Lung Ventilation Controller (ALV-Controller) represents a new approach to closed loop control of ventilation. It is based on a pressure controlled ventilation mode. Adaptive lung ventilation signifies automatic breath by breath adaptation of breathing patterns to the lung mechanics of an individual patient. The specific goals are to minimize work of breathing, to maintain a preset alveolar ventilation and to prevent the occurrence of intrinsic PEEP. We ventilated 5 patients undergoing major abdominal procedures using ALV. ALV was tolerated well in all patients. Alveolar ventilation was preset between 5500 and 6500 ml/min. Serial dead space (Vds) and respiratory time constant (resistance * compliance) of the patients ranged from 104 to 164 ml and 0.74 to 1.5 s, respectively. The resulting respiratory rates ranged from 8 to 15 breaths/min, the tidal volumes from 542 to 829 ml, and the applied maximum inspiratory pressures from 15.5 to 18.9 mbar. Expiratory time was sufficient in all cases to allow complete expiration and to avoid intrinsic PEEP. I: E-relations ranged from 0.36 to 0.76. After a step change in alveolar ventilation rise times of the breathing patterns were recorded at values from 7 to 67 s. Overshoot did not reach statistic significance compared to the variations in breathing patterns which occurred during stable measuring periods. Accuracy of the controller was high (27.8 ml difference between preset and applied alveolar ventilation in the mean) and stability was sufficient for clinical purposes. The results of this preliminary study show that the breathing patterns selected by the controller were well adapted to the lung mechanics of the patients. Respiratory rates, inspiratory pressures and tidal volumes were within the clinically acceptable range in all patients.

Adult

An adaptive lung ventilation controller.

Closed loop control of ventilation is traditionally based on end-tidal or mean expired CO2. The controlled variables are the respiratory rate RR and the tidal volume VT. Neither patient size or lung mechanics were considered in previous approaches. Also the modes were not suitable for spontaneously breathing subjects. This report presents a new approach to closed loop controlled ventilation, called Adaptive Lung Ventilation (ALV). ALV is based on a pressure controlled ventilation mode suitable for paralyzed, as well as spontaneously breathing, subjects. The clinician enters a desired gross alveolar ventilation (V'gA in l/min), and the ALV controller tries to achieve this goal by automatic adjustment of mechanical rate and inspiratory pressure level. The adjustments are based on measurements of the patient's lung mechanics and series dead space. The ALV controller was tested on a physical lung model with adjustable mechanical properties. Three different lung pathologies were simulated on the lung model to test the controller for rise time (T90), overshoot (Ym), and steady state performance (delta max). The pathologies corresponded to restrictive lung disease (similar to ARDS), a "normal" lung, and obstructive lung disease (such as asthma). Furthermore, feasibility tests were done in 6 patients undergoing surgical procedures in total intravenous anesthesia. In the model studies, the controller responded to step changes between 48 seconds and 81 seconds. It did exhibit an overshoot between 5.5% and 7.9% of the setpoint after the step change.(ABSTRACT TRUNCATED AT 250 WORDS)

Equipment Design

[Modification of oxygen consumption following major abdominal surgery by epidural anesthesia].

In the postoperative period patients are at risk of excessive oxygen consumption (VO2). However, patients suffering from cardiovascular disease may be unable to increase their oxygen transport capacity sufficiently and may be especially vulnerable to tissue hypoxia as part of the reaction to intraoperative stress. During the last 10 years conflicting results concerning the benefits of a combined epidural and light general anaesthesia have been published. Some of the results indicate that postoperative catabolism may be depressed and that the neuroendocrine response to stress may be inhibited by such a combined technique. We studied the effect of a combined epidural and light general anaesthesia on VO2 in the early post-operative period. PATIENTS AND METHODS. Three groups of patients were studied: group 1 contained 10 patients scheduled for major urological procedures of at least 3 h duration who received a combined epidural and light general anaesthesia. Group 2 contained 17 patients with procedures comparable to group 1 but received a standard general anaesthesia with isoflurane, N2O and fentanyl. In addition, 13 patients undergoing minor urological procedures of less than 2 h duration and undergoing standard general anaesthesia were included in the study as a control group (group 3). All patients gave informed consent. Preoperative management was the same in the three groups. Perioperative risk was assessed according to the ASA classification. In group 1 patients, an epidural catheter was placed preoperatively at the L3/4 interspace and tested for correct positioning using 4 ml of 2% mepivacaine with epinephrine 1:200,000. After induction of anaesthesia an epidural block was established with 0.5% bupivacaine for intraoperative analgesia and 0.25% bupivacaine for postoperative pain relief. The initial dosage was determined (according to Bromage's method) to reach a sensory level of T-6. Two-thirds of the initial dose was the given on two occasions, each 90 min after the dose before. End-tidal isoflurane concentrations ranged between 0.3 and 0.6 vol% in this group. In groups 2 and 3, endtidal isoflurane concentrations of 1.0 to 1.5 vol% were applied. Postoperative analgesia was achieved in these groups using repeated doses of 7.5 mg piritramide i.v. Oxygen consumption was measured in the recovery room using the Deltatrac (Datex) metabolic monitor. Measurements were performed with a canopy room air dilution technique. Arterial oxygen saturation of the patients was monitored continuously using pulse oximetry. Data acquisition was started within 10 min after extubation and continued for at least 60 min until a steady state of oxygen consumption was reached. We recorded the average VO2 during the initial 5 min of the measurement period and during another 5-min period after the steady state was reached (45-60 min after extubation). RESULTS. Patients in the three groups were comparable in age, height and body weight (Table 1). The duration of procedures in groups 1 and 2 ranged between 4 and 7 h. Groups 1 and 2 were further comparable in terms of intraabdominal procedures, intraoperative blood loss, fluid replacement, and fall in body temperature during the operation (Table 2). Heart range was significantly higher in group 2 during the 5-min test interval (Table 3). Figure 1 shows the typical course of oxygen consumption in patients of groups 1, 2, and 3. The readings in the group 1 patient as well as in the group 3 patients were stable throughout the observation period. Oxygen consumption was in the physiological range. In contrast, in the group 2 patients during the early postoperative period, increased values of VO2 (approx. 50% above normal) were observed. These findings were highly significant in our study. In the early postoperative period (5 min) patients in group 1 showed a VO2 or 3.6 +/- 0.4 ml.kg-1.min-1. This was the same as in group 3 (3.5 +/- 0.3 ml.kg-1.min-1). In contrast, in group 2 a VO2 of 5.3 +/- 0.7 ml.kg-1.min-1

Abdomen

[Modern forms of artificial respiration].

Mechanical ventilation has become a widely used technique in anaesthesiology and intensive care medicine. Difficulties arise with patients who suffer from acute or chronic pulmonary disease. Lung models are used to simulate the behaviour of healthy and diseased lungs and to optimize breathing patterns. Flow-controlled ventilation is suitable for healthy lungs. Diseased lungs need more finely differentiated ventilatory modes that adapt to the different time constants within the lung. PCV seems to have some advantages in ventilation of such lungs. It has been demonstrated that prolongation of inspiratory time and inversion of the I:E ratio can open nonventilated compartments of the lung and thus reduce intrapulmonary shunt. BiPAP ventilation and APRV serve the same purpose. Additionally, they support spontaneous breathing of the patient. Weaning from the respirator can be achieved by either reducing the number of mandatory breaths (IMV, SIMV, MMV) or reducing the work of breathing by applying inspiratory pressure support (PSV). Both techniques can be applied simultaneously. BiPAP ventilation and APRV are also suitable for weaning patients from a ventilator. Respirators able to adapt breathing patterns to the lung mechanics of a patient automatically on the basis of a breath-to-breath lung function analysis (ALV) are currently in clinical development.

Humans

[Propofol for sedation during postoperative mechanical ventilation. A comparative study with Lytic Mixture].

Propofol infusion was found to provide excellent sedation and rapid recovery in intensive care. The present study compared Propofol with lytic solution (lytic solution = mixture of 100 mg Pethidine, 50 mg Promethazine and 0.6 mg Dihydroergotamine) during 6 hours of postoperative artificial ventilation. 60 patients after major abdominal surgical procedures were studied with ethical committee approval and informed consent. Patients were randomly allocated to receive either Propofol or lytic solution. We aimed at a sedation level of stage 5 according to the Ramsey score. The mean drug dosages were 3.9 mg/kg/h of Propofol and 4.2 ml/h of lytic solution. Hemodynamic values, blood gases as well as various biochemical measures did not show any difference between the groups. At the end of the sedation period triglyceride concentrations were significantly higher in patients receiving Propofol (166 + 79 mg/dl) compared to the control group (97 + 60 mg/dl). Significant and relevant differences were found for the times of recovery after discontinuation of the sedative. These times were very short in the Propofol group. Furthermore, in view of a longer recovery time after lytic solution in this group the respiratory rate was significantly slower up to the end of the observation period. We conclude that a major advantage of Propofol in the present study was the rapid recovery after 6 hour sedation. Patients gain vigilance rapidly and sufficient spontaneous respiration within minutes. Not at least thanks to these facts patient's safety can be improved in the recovery period.

Abdomen

[Registration and analysis of airway pressure and gas flow in ventilated patients. The "Hyper-DAQ Respiration Mechanics Recorder"].

Respiratory data monitored in ventilated patients commonly consists of monitoring some inspiratory and expiratory pressures and volumes. For a more sophisticated analysis of respiratory mechanics in ventilated patients, a combined hardware and software system is presented that allows for continuous monitoring of airway pressure and gas flow. Gas flow is measured using a pneumotach. The "Hyper-DAQ" is an 8-channel 12-bit analog to a digital converter that can be connected to IBM PCs as well as to Macintosh computers using a standard RS 232 link. A special module consisting of three pressure transducers (airway pressure, differential pressure for a Fleisch head and ambient pressure) and five additional analog inputs is used for recording respiratory data. Once set up, the Hyper-DAQ records all the data in real time, independently of the host system that can query the data via the RS 232 link. The software runs on IBM and compatible PCs, as well as on Macintosh computers. The software simulates a strip-chart recorder and can be controlled by the keyboard and the mouse. We developed special software for the calibration of pressure and flow. Using models of the gas distribution in the lung compliance, resistance and lung time constants can be calculated from the raw data. For special purposes the data can be transferred to spread-sheet software. A mainstream CO2-detector connected to one of the additional analog inputs allows for additional data: alveolar ventilation, series deadspace, etc. The system presented can be recommended in routine work as well as for scientific studies in ventilated patients.

Anesthesiology